Fungemia clinical trials
The registry lists 25 studies for Fungemia across more than 10 countries. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-25.
Status
- Completed
- 17
- Status unknown
- 4
- Terminated
- 2
- Recruiting
- 2
Phase
- Phase 3
- 6
- Phase 4
- 2
- Phase 2
- 2
Where
- United States
- 12
- Belgium
- 4
- Italy
- 4
- Spain
- 3
- France
- 3
- Canada
- 3
Who runs them
University of Pittsburgh (2) · National Cancer Institute (NCI) (2) · Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne (1) · Taipei Medical University WanFang Hospital (1) · University Hospital, Grenoble (1) · Hunter Holmes Mcguire Veteran Affairs Medical Center (1) · Tan Tock Seng Hospital (1) · Fundacion SEIMC-GESIDA (1)
Studies
Recruiting first, then most recently updated. Showing 25 of 25 — search for more.
- Clinical Efectiveness of a Multiplex PCR-Based Rapid Diagnostic Method in Bloodstream InfectionsRecruitingNCT074085441 country
- The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and FungemiaRecruitingNCT06576258Not applicable1 country
- Metagenomic Sequencing for the Identification of Pathogens in Febrile Neutropenic PatientsTerminatedNCT06075888Not applicable1 country
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 39 countries
- Clinical and Medico-economic Evaluation of a Rapid Test (ePlex-BCID®, GenMark) for the Diagnosis of Bacteremia and Fungemia.CompletedNCT03876990Not applicable1 country
- Clinical Evaluation of Novel Biomarkers in Patients With SepticemiaCompletedNCT013598911 country
- CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging ExtensionCompletedNCT02734862Phase 210 countries
- Retrospective Chart Review of Candida FungemiaCompletedNCT038273301 country
- Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT)Status unknownNCT02743585Not applicable1 country
- Clinical Performance of the Accelerate ID/AST System for Positive Blood CultureCompletedNCT027197691 country
- Fungemia in Hematologic MalignanciesCompletedNCT024515921 country
- Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.CompletedNCT01450358Phase 41 country
- A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal InfectionsCompletedNCT00794703Phase 31 country
- Rapid Identification and Susceptibility Testing of Pathogens From Blood CulturesCompletedNCT01898208Not applicable1 country
- Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant RecipientsCompletedNCT00841971Phase 41 country
- An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To CandidaTerminatedNCT00805740Phase 39 countries
- Prospective Population Study on Candidemia in SpainCompletedNCT012362611 country
- Voriconazole as Prophylaxis for Liver Transplant RecipientsCompletedNCT001777881 country
- Caspofungin as Prophylaxis in High Risk Liver Transplantation RecipientsStatus unknownNCT01260974Phase 21 country
- The Relationship Between Morphology and Virulent Genes of Candida Albicans and Clinical Aspects, Surveillance of FungemiaStatus unknownNCT012110411 country
- An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsCompletedNCT00001810Phase 31 country
- Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant PatientsCompletedNCT00001937Phase 31 country
- Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCTStatus unknownNCT004603301 country
- The Impact of Chlorhexidine-Based Bathing on Nosocomial InfectionsCompletedNCT004489421 country
- Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream InfectionsCompletedNCT00027248Phase 31 country